BPH Global Limited is a plant-focused biotechnology company specializing in the research, development, production, and commercialization of products rooted in Traditional Chinese Medicine (TCM). The company develops and supplies a range of foods, nutritional supplements, healthcare, and cosmetic items that incorporate ingredients such as bird’s nest, sea grapes (Caulerpa lentillifera), various seaweeds, and other marine or plant-based sources. BPH Global Limited operates with a concentrated focus on TCM-based health outcomes, serving core markets in Australia, China, Singapore, Indonesia, and Southeast Asia.

Established in 1984 and headquartered in Melbourne, BPH Global Limited's activities bridge the pharmaceuticals, biotechnology, and specialty drug manufacturing sectors. Its offerings are positioned at the intersection of sustainable plant-based solutions and traditional medicine, targeting applications in food, nutrition, healthcare, and personal care industries. The company’s business model is centered on sourcing, producing, marketing, and selling TCM products, reflecting broader trends in alternative medicines and health-conscious consumer demand. BPH Global Limited is also notable for its plant-based product portfolio, addressing growing interest in natural and functional therapeutics within the broader healthcare sector.